Charged Alpha Stock Encyclopedia

Hello Group (MOMO) Q2 2026 — Shares closed down 7.1% to $5.10 the session the print landed, a new 12-month low.
Hello Group's market value has fallen below its liquid cash. At $5.10 an ADS the company carries $8.04 a share in cash and deposits and effectively no debt, which puts enterprise value at roughly NEGATIVE $460 million. The Q2 print is the first one that lets you audit both halves of why: what it costs to get that cash out of China, and whether the operating business underneath it is worth anything at all.
THE CALL: BULLISH (3/5, MODERATE) — base-case value ~$8.70 vs ~$5.10 today.
KEY METRICS:
- Net revenues RMB2,486.0M (US$366.4M), -5.1% YoY
- Chinese mainland revenue -16.7%; overseas revenue +52.0% to RMB672.7M
- Overseas now 27.1% of revenue, up from 16.9% a year ago
- Income from operations RMB238.0M, -41.0% YoY; operating margin 15.4% to 9.6%
- GAAP diluted RMB1.52 (US$0.22) per ADS; non-GAAP RMB1.75 (US$0.26)
- The profit swing is the absence of last year's RMB547.9M WFOE withholding tax accrual
- Cash, deposits and short-term investments RMB8,542.4M (US$1,259.0M); total borrowings RMB3.5M
- Momo app paying users 3.5M to 3.9M; Tantan 0.7M to 0.5M
- Buyback: 68.0M ADSs for US$424.1M at an average $6.22; only US$62.0M of authorization left
- Q3 2026 guide RMB2.4-2.5B, a 5.7% to 9.4% decline - steeper than Q2's 5.1%
What to watch: The board re-authorizes the share repurchase program before the remaining $62.0M runs out, and overseas revenue growth holds above 30% year over year
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Elevra Lithium Limited (ELVR) FY2026 — Shares fell about 4% the first session after the results reached the market and have kept sliding since, down nearly 8% from before the print.
Elevra Lithium posted its first full-year profit ever, $44 million. The same year, net cash from operating activities was negative $44 million - the identical number, the opposite direction. Most of the headline profit is two non-cash entries, a $156 million impairment reversal and a $33 million merger accounting gain, while underlying EBITDA was just $14 million and the $255 million cash balance came almost entirely from a dilutive equity raise, not from selling lithium.
THE CALL: SELL (2/5, CAUTIOUS) — base-case value ~$15 vs ~$56.78 today.
KEY METRICS:
- Revenue $202M, +39% YoY, on realized price +57% to $1,092/dmt; sales volume -13% to 181,494 dmt
- Underlying EBITDA +$14M (vs -$43M FY25); profit after tax +$44M (vs -$247M FY25)
- Profit driven by a $156M non-cash impairment reversal + $33M merger bargain-purchase gain, partly offset by $104M of non-cash merger accounting charges
- Net cash from operating activities -$44M (vs -$10M FY25) - the same magnitude as the profit, opposite sign
- Cash balance $255M, up $208M, almost entirely from a $202M equity raise plus Piedmont cash absorbed in the merger
- Unit operating cost (FOB) $853/dmt, +2% YoY; FY27 guide $880-950/dmt on 198-210k dmt production
- Audited net assets $727M vs a market value near $4.02B (5.9x); fair value $15 vs a $56.78 price
What to watch: another year of negative operating cash flow, a second dilutive raise, or realized lithium price sliding back toward last year's $694/dmt
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

UiPath, Inc. (PATH) Q2 FY2027 — Shares fell roughly 7.7% to $16.81 in early trading after UiPath posted its first GAAP operating profit in a Q2, cut stock-based comp 42% year over year, and disclosed a leadership reshuffle alongside the softest net-new-ARR quarter in this data.
UiPath spent three straight fiscal years posting a GAAP operating loss. This quarter it posted a $32 million operating profit, cut its own stock-based compensation nearly in half year over year, and for the first time the buyback actually shrank the diluted share count. The stock still fell about 8% in after-hours trading, because the print also carried the softest bookings quarter in this data and a three-way leadership reshuffle in the same release.
THE CALL: HOLD (3/5, MODERATE) — base-case value ~$15.13 vs ~$16.81 today.
KEY METRICS:
- Revenue $410.3M, +13% Y/Y; GAAP operating income $31.6M vs a $20.2M loss a year ago
- Stock-based comp $45.0M vs $78.0M a year ago, -42% Y/Y; 11.0% of revenue vs 21.6%
- Diluted weighted-average shares 523.0M vs 542.9M a year ago, -3.7% Y/Y
- H1 buyback $268.5M vs $329.1M a year ago; treasury stock +$258.9M in six months
- ARR $1.938B, +12% Y/Y; net new ARR only $37M; net retention 109%
- Non-GAAP operating income $89.0M, 22% margin, +43% Y/Y; non-GAAP diluted EPS flat at $0.15
- $1.405B cash and marketable securities, no interest-bearing debt
- Leadership reshuffle: COO narrows mandate, deputy CFO promoted to CFO, new board member added
- Street average target $16.50 across 4 firms with a live number vs our fair value $15.13
What to watch: Net new ARR back above $50 million AND stock-based comp held under 15% of revenue for two more quarters would move the call toward a buy; a slide back toward last year's SBC intensity or continued sub-$40M net new ARR would not.
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Ambarella, Inc. (AMBA) Q2 FY2027 — It fell roughly 3.4% in after-hours trading after the print, on top of a slide from a 12-month high near $95.51 down into the low sixties.
Ambarella's reported net loss narrowed 68% year over year, from $(0.47) to $(0.15) per share. But a one-time $9.0 million credit released from R&D after a cancelled project is worth $0.20 of that improvement - restated, the loss only narrowed 23%. Meanwhile gross margin, the honest read on the actual chip business, fell on both GAAP and non-GAAP bases for a fifth straight year, even as revenue grew 13.2%.
THE CALL: HOLD (3/5, MODERATE) — base-case value ~$57 vs ~$61.24 today.
KEY METRICS:
- Revenue $108.1M, +13.2% YoY; non-GAAP EPS $0.18 beat; GAAP diluted loss $(0.15)/sh
- A $9.0M one-time R&D credit (cancelled-project deposit release) is worth $0.20/sh - ex-credit, the loss narrowed 23%, not the reported 68%
- GAAP gross margin 57.7% vs 58.9% a year ago; non-GAAP 59.3% vs 60.5% - both down 120bp, fifth straight year of decline
- Incremental gross margin on new revenue is only 49%, against a 57.7% company average
- Revenue is $0.3M below its level three quarters ago - four quarters effectively flat around $104M/quarter
- $272.3M cash + securities, zero debt ($6.15/sh); inventory +47.2% in six months to 153 days of COGS
- Street average price target $101.75 (all pre-print) vs our fair value $57
What to watch: adjusted gross margin falling back under 59%, another inventory build without matching revenue growth, or an October revenue print at the low end of guidance
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Samsara (IOT) Q2 FY2027 — Shares closed up 5.3% to $38.75 the session the print landed.
Samsara posted its best quarter of profitability in company history — non-GAAP operating margin jumped from 15% to 21% and GAAP operating income turned positive — then guided Q3 revenue growth down to 24%, six points below the 30% it just reported.
THE CALL: BEARISH (2/5, LOW-MODERATE) — base-case value ~$17.90 vs ~$38.75 today.
KEY METRICS:
- Revenue $508.4M, +30% YoY (29% constant currency)
- ARR $2.12B, +30% YoY; net new ARR $134.1M, +28% YoY
- Non-GAAP operating margin 21% vs 15% a year ago
- GAAP operating income $4.9M vs -$26.6M a year ago
- Free cash flow $64.7M, 13% margin vs 11% a year ago
- Q3 FY2027 guide: $514-516M revenue, 24% YoY growth
- FY2027 guide: $2.043-2.047B revenue, 26% YoY growth, 21% non-GAAP operating margin
- Cash + investments $1.33B, no debt
- Our fair value $18.50 vs $38.75 close (bear $10.45 / base $17.90 / bull $29.24)
- Wall Street average target $44.29 across 7 dated ratings (13 buy, 5 hold, 0 sell of 18 firms)
What to watch: Q3 revenue growth prints at or above the 24% guide and non-GAAP operating margin holds 21%+ for two more quarters
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Snowflake, Inc. (SNOW) Q2 FY2027 — Shares rose 16.6% to $356.47, a new 12-month high, after Snowflake beat on revenue and raised its FY2027 product-revenue and operating-margin guidance for a second consecutive quarter, while leaving the adjusted free-cash-flow-margin guide unchanged at 23.0% for the third straight update.
Snowflake has now guided its fiscal 2027 adjusted free cash flow margin at 23.0% three times this year without moving a single basis point, while raising its product-revenue guide twice and its operating-margin guide twice over the same three filings. The stock is up 16.6% since the print and sitting at a new 12-month high; our fair value is about $120, roughly a third of where it closed.
THE CALL: AVOID (3/5, MODERATE) — base-case value ~$120 vs ~$356.47 today.
KEY METRICS:
- FY27 adjusted FCF margin guided 23.0% three times running - product revenue guide raised $5,660M to $5,840M to $6,070M
- H1 non-GAAP operating margin 10% to 14%, but H1 adjusted FCF margin went DOWN, 12.5% to 12.2%
- Deferred revenue -$778M (-23%) since January; calculated billings growth 16.1% vs revenue growth 35.1% - a 19-point gap
- Owner earnings (adjusted FCF less stock comp), TTM -$479M; base-case fair value ~$120 charges stock comp in full
- Ignore stock comp entirely and the same operating case gives $203 - one accounting choice is worth about $83 a share
- Reverse DCF at the $356.47 close demands 28.6% a year of revenue growth to FY2036, up from 26.3% at the $305.84 pre-print close
- Stock up 16.6% since the print to a new 12-month high, 5.7% clear of the prior high of $337.38
- Street: 42 buy / 9 hold / 1 sell across 52 analysts, median target $440 (+23% from the close), 21 raises and zero cuts post-print
What to watch: A January deferred-revenue build over $900M, two straight quarters of billings growth within 5 points of revenue growth, and stock compensation falling under 25% of sales would move the call toward a buy; a full-year adjusted free cash flow margin finishing under 23.0% would not.
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Argan, Inc. (AGX) Q2 FY2027 — It is +0.33% since the print - essentially flat - after already being cut roughly in half from its June high.
Argan just posted a record quarter and a headline cash balance of $1,028.4M, or $73.30 a share - but $627.0M of that is customer prepayments. Net of those, real liquidity is only $440.4M, or $31.39 a share. Meanwhile the order book has fallen three quarters running, down 16.1% off its October peak.
THE CALL: AVOID (3/5, MODERATE) — base-case value ~$287 vs ~$411.77 today.
KEY METRICS:
- Record revenue $383.976M, +61.5% YoY; EPS $3.76, no debt
- Order book -16.1% off its October peak - three straight quarterly declines
- Net liquidity $440.4M ($31.39/sh) vs headline cash $1,028.4M ($73.30/sh apparent)
- Book-to-bill ~0.39x this half; contract liabilities $627.0M, +$113.1M in the half
- Power segment alone is 96.9% of the entire consolidated gross-profit increase
- Tax rate 20.3% vs 1.0% a year ago - re-taxed EPS growth is ~87%, not the headline +50%
- Street average price target $559 vs our fair value $287
What to watch: a fourth straight quarterly backlog decline, Power segment gross margin falling under 20%, or contract liabilities starting to shrink
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

The Campbell's Company (CPB) Q4 FY2026 — Shares fell 6.9% to $22.13 on roughly seven times average volume after Campbell's cut its quarterly dividend 36% and guided fiscal 2027 below where the leverage ratio actually improves.
Campbell's generated $1,039 million of operating cash flow in fiscal 2026 and ended the year owing $280 million more in gross borrowings than when it started. This morning it cut the dividend 36% explicitly to accelerate debt reduction - but the same release guided adjusted EBIT down enough that net debt to EBITDA does not actually improve in fiscal 2027, even in the company's best case.
THE CALL: HOLD (3/5, MODERATE) — base-case value ~$21.82 vs ~$22.13 today.
KEY METRICS:
- Dividend cut 36% - $0.39 to $0.25 quarterly, $1.56 to $1.00 annualized
- Gross borrowings $6,857M to $7,137M, +$280M, despite $1,039M of operating cash flow
- Net debt / adjusted EBITDA: FY2025 3.50x -> FY2026 4.23x -> FY2027E 4.21x best / 4.55x worst
- Adjusted EPS trail: FY24 $3.08 -> FY25 $2.97 -> FY26 $2.17 -> FY27E $1.65-$1.80
- Impairments $293M over two years (Kettle Brand, Cape Cod, Snyder's of Hanover), all excluded from adjusted EPS
- FY2026 missed its own guidance on all four metrics - sales -3.4% vs a -2%/0% guide
- Cost-savings target raised twice: $250M by FY2028 -> $375M by FY2028 -> $500M by FY2030
- Street average target $20.12 across 9 firms vs our fair value $21.82
What to watch: Two quarters of positive Snacks organic volume, or net debt to adjusted EBITDA improving below roughly 4.2x at the December Q1 FY2027 print, would move the call toward a buy; another guidance miss on the FY2027 numbers would not.
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Five Below (FIVE) Q2 FY2026 — It has gone nowhere since the print, having already run 90% off its October low.
Five Below reported diluted EPS of $3.99 - and $2.33 of that was a one-time IEEPA tariff refund booked inside cost of goods sold, which is why COGS FELL 5.2% while net sales rose 22.9%. Strip it out and adjusted EPS was $1.68, still up 107% and still 20% ahead of the Street, on comparable sales up 14.1%. The harder question is whether the margin expansion is a second, quieter tariff benefit - and it is not. Q1 carried no refund at all and still expanded gross margin 386bp. Per point of comp, Q2 earned LESS margin than Q1, not more. The gain is fixed-cost absorption. Which is exactly the problem, because the company's own guidance has the comp decelerating from +14.1% to the low single digits by Q4.
THE CALL: HOLD (3/5, MODERATE) — base-case value ~$215.0 vs ~$241.42 today.
KEY METRICS:
- Net sales $1,261.5M, +22.9% YoY; comparable sales +14.1%, a fifth straight double-digit quarter
- GAAP diluted EPS $3.99 vs adjusted $1.68 - the gap is a $163.6M IEEPA tariff refund ($2.33/share)
- That refund was 58.3% of reported net income, and it was booked inside cost of goods sold
- Adjusted gross margin 35.60% vs 33.43%; adjusted operating margin 8.97% vs 5.37%
- Q1 FY2026 carried NO refund and still expanded gross margin 386bp on a +22.7% comp
- Margin earned per point of comp: 17.0bp in Q1, 15.4bp in Q2 - lower, so no hidden tariff benefit
- FY26 outlook raised: GAAP EPS midpoint +$3.52, but adjusted only +$1.22 - just 35% is operating
- Q3 comps guided +8% to +10%; FY +10% to +12% against +18.3% delivered in H1
- $1,187.9M cash and investments, zero debt, new $600M buyback (4.5% of market cap)
- 24.0x FY26 adjusted EPS guidance of $10.07 - the 19.6x GAAP multiple is inflated by the refund
What to watch: the Q3 release in December - does the comp beat the +8% to +10% guide, and does gross margin still convert 15-17 basis points per point of comp
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Petco (WOOF) Q2 FY2026 — It gapped more than 20% higher on the print and handed the whole move back within the session.
Petco reported second-quarter net income of $38.7M against $14.0M a year ago - but $16.5M of that $24.7M increase is the income tax line, which swung from a $0.7M charge to a $15.7M credit. Strip the $6.8M IEEPA tariff refund the company quantifies and operating income actually fell 4.7%.
THE CALL: HOLD (3/5, MODERATE) — base-case value ~$3.00 vs ~$2.57 today.
KEY METRICS:
- Net sales $1,489.2M, +0.05% YoY - below the ~+0.3% Petco guided in June
- Comparable sales +0.6% - a second consecutive positive quarter
- Adjusted EBITDA $122.2M vs a $110-112M guide; $115.4M without the tariff refund
- Net income $38.7M vs $14.0M - but $16.5M of the $24.7M rise is income tax
- Operating income $47.8M; ex the $6.8M IEEPA refund $41.0M, down 4.7% YoY
- H1 free cash flow $60.8M vs $9.9M; net debt $1,186.4M = 2.80x adjusted EBITDA
- FY2026 outlook reaffirmed at $415-430M adjusted EBITDA for a third time
What to watch: the Q3 release in late November - does adjusted EBITDA clear the $100-103M guide without a tariff refund, and does the reaffirmed full-year range finally move
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.